(Q42282807)

19 October 2017

title

Protein S and protein C level changes with adjuvant tamoxifen therapy in postmenopausal women (English)

1 reference

19 October 2017

1 reference

C C Mamby

1

1 reference

19 October 2017

R R Love

series ordinal

2

1 reference

19 October 2017

J M Feyzi

series ordinal

3

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

Breast Cancer Research and Treatment

19 October 2017

published in

1 reference

19 October 2017

volume

30

1 reference

19 October 2017

issue

3

1 reference

19 October 2017

page(s)

311-314

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00665973

19 October 2017

exact match

0 references

cites work

Effects of tamoxifen on blood coagulation

1 reference

12 December 2020

Antithrombin III Level, Fibrinogen Level, and Platelet Count Changes With Adjuvant Tamoxifen Therapy

1 reference

12 December 2020

The Wisconsin Tamoxifen Study: toxicity in node-negative postmenopausal women

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00665973

1 reference

Dimensions Publication ID

19 October 2017

1029669916

0 references

Fatcat ID

release_ntujcorffvey7ondeh5k3a6xxa

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ntujcorffvey7ondeh5k3a6xxa

24 November 2022

mapped directly with Wikidata item

1 reference